GE Healthcare, a subsidiary of General Electric Co. (NYSE:GE), and Fujifilm Corp. (NASDAQ:FUJI) have announced a
strategic alliance to develop biomolecular imaging systems. Fujifilm will supply image analyzing systems for bioscience research, and GE Healthcare will market and sell them under the GE brand. The companies will also collaborate to develop customized imaging systems optimized for customer applications.
GE Healthcare has been reshaping its business for the past year, bulking up in the digital medical space and shedding slower growth units. It announced a
partnership with Intel Corp. (NASDAQ:INTC) in April to offer digital solutions to doctors and patients, and paid $860 million in October for the
medical products maker Vital Signs Inc. It's also divested businesses, including its patient statement business to Emdeon Inc. in September, and its CodeLink Activated Slide business to SurModics Inc. (NASDAQ:SRDX) a month later.
Fujifilm, meanwhile, has spent the past two decades transforming from a photography-focused business to a comprehensive healthcare and technology company. It began applying its photo-imaging technology to healthcare applications in 1987, when, according to the company, it introduced a digital autoradiography device with sensitivity 100 times greater than X-ray film. And it has expanded into materials, providing technology used in flat-panel display devices and graphic systems.
- Suzanne Stevens
Join Corporate Dealmaker's LinkedIn forum
Juergen Lasowski
And the winners are...
